The label should clearly state: drug name (semaglutide or tirzepatide), concentration (mg/mL), total volume (mL), any additives (such as B12 or niacinamide), lot number, expiration date, and the compounding pharmacy name
Clinical trial participation, identified via the NIHR 'Be Part of Research' portal, ClinicalTrials.gov, or the ISRCTN registry, is the only currently regulated access route in the UK
Semaglutide has two primary uses: Type 2 diabetes and Weight Management the dosing varies depending upon the indication
The mechanisms underlying these adverse effects of GLP-1R agonists remain to be elucidated
Do Founds medications have side effects
By targeting the GLP-1 hormone pathway, it effectively suppresses appetite and improves blood sugar control, leading to significant weight loss for many users